Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Feb;126(4):841-4.
doi: 10.1038/sj.bjp.0702385.

Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene

Affiliations

Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene

M G Scott et al. Br J Pharmacol. 1999 Feb.

Abstract

By screening the 1470 bp 5' to the start codon of the human beta2 adrenergic receptor gene, we have identified a total of eight polymorphisms (-20 T-->C, -47 T-->C, -367 T-->C, -468 C-->G, -654 G-->A, -1023 G-->A, -1343 A-->G and -1429 T-->A c.f. beta2 adrenergic receptor start codon). Transient transfection of 5' flanking deletion luciferase reporter constructs demonstrated the majority of activity of the human beta2 adrenergic gene 5' flanking region to be present within a 549 bp fragment immediately upstream from the start codon. Because of linkage disequilibrium, some combinations of polymorphisms were particularly frequent. We transiently transfected COS-7 cells with luciferase constructs under the control of the 549 bp of 5' flanking DNA containing the two most frequent extended haplotypes in this region. Luciferase activity was significantly reduced in cells transfected with the 'mutant' construct (-20C, -47C, -367C, -468G) c.f. the 'wild-type' construct (-20T, -47T, -367T, -468C). These data suggest that polymorphisms have the potential to alter human beta2 adrenergic receptor gene expression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative promoter activity of the human β2 adrenergic receptor gene in COS-7 cells. Schematic drawings of the constructs, indicating the restriction enzyme sites used for subcloning into pGL3 Enhancer, are shown on the left. Nomenclature of the constructs refers to the number of nucleotides (in kbp) of 5′ flanking region relative to the translational start codon. Firefly luciferase activity was normalized to Renilla luciferase activity of the co-transfected plasmid pRL.CMV to correct for variation in transfection efficiency. The results are expressed relative to the backbone vector pGL3 Enhancer. pGL3 Control, which contains the luciferase cDNA under the control of both SV40 promoter and enhancer elements, was used as a positive control. Each bar represents the mean±s.e.mean from triplicate determinations in individual experiments, n=7–19. Where error bars are not shown they lie within the bar.

References

    1. DEWAR J.C., HALL I.P. A novel degenerate polymorphism in the human histamine H1 receptor gene. Am. J. Respir. Crit. Care Med. 1998;157:A773.
    1. EMORINE L.J., MARULLO S., DELAVIERKLUTCHKO C., KAVERI S.V., DURIEUTRAUTMANN O., STROSBERG A.D. Structure of the gene for human beta-2-adrenergic receptor expression and promoter characterization. Proc. Natl. Acad. Sci. U.S.A. 1987;84:6995–6999. - PMC - PubMed
    1. GREEN S.A., COLE G., JACINTO M., INNIS M., LIGGETT S.B. A polymorphism of the human β2-receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 1993;268:23116–23121. - PubMed
    1. GREEN S.A., TURKI J., BEJARANO P., HALL I.P., LIGGETT S.B. Influence of β2 adrenergic receptor gentoypes on signal transduction in human airway smooth muscle cells. Am. J. Resp. Cell Mol. Biol. 1995;13:25–33. - PubMed
    1. KOBILKA B.K., FRIELLE T., DOHLMAN H.G., BOLANOWSKI M.A., DIXON R.A.F., KELLER P., CARON M.G., LEFKOWITZ R.J. Delineation of the intronless nature of the genes for the human and hamster β2 adrenergic receptor and their putative promoter regions. J. Biol. Chem. 1987;262:7321–7327. - PubMed

Publication types

Substances

LinkOut - more resources